Wednesday, October 16, 2019 10:45:50 PM
A lot depends on whether or not the company continues financing itself with convertible debt.
I've read they have plans of becoming a legitimate company and perhaps even uplisting to NASDAQ. I'm in favor of that, but easy money is addictive. So we shall see.
I think there's going to be some price fluctuation and appreciation ... But how high and how long is the proverbial question. We shall see.
Watch for opportunities with those you trust.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM